19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells

      1 , 2 , 1 , 2 , 1 , 2 , 1 , 2 , 3 , 2 , 4 , 2 , 1 , 2 , 4 , 4 , 1 , 2 , 4 , 1 , 2 , 1 , 2 , 5 , 2 , 2 , 6 , 6 , 7 , 8 , 9 , 10 , 6 , 6 , 6 , 6 , 11 , 4 , 2 , 12 , 13 , 14 , 15 , 6 , 16 , 1 , 2 , 4
      Science Translational Medicine
      American Association for the Advancement of Science (AAAS)

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Acute tissue injury causes DNA damage and repair processes involving increased cell mitosis and polyploidization, leading to cell function alterations that may potentially drive cancer development. Here, we show that acute kidney injury (AKI) increased the risk for papillary renal cell carcinoma (pRCC) development and tumor relapse in humans as confirmed by data collected from several single-center and multicentric studies. Lineage tracing of tubular epithelial cells (TECs) after AKI induction and long-term follow-up in mice showed time-dependent onset of clonal papillary tumors in an adenoma-carcinoma sequence. Among AKI-related pathways, NOTCH1 overexpression in human pRCC associated with worse outcome and was specific for type 2 pRCC. Mice overexpressing NOTCH1 in TECs developed papillary adenomas and type 2 pRCCs, and AKI accelerated this process. Lineage tracing in mice identified single renal progenitors as the cell of origin of papillary tumors. Single-cell RNA sequencing showed that human renal progenitor transcriptome showed similarities to PT1, the putative cell of origin of human pRCC. Furthermore, NOTCH1 overexpression in cultured human renal progenitor cells induced tumor-like 3D growth. Thus, AKI can drive tumorigenesis from local tissue progenitor cells. In particular, we find that AKI promotes the development of pRCC from single progenitors through a classical adenoma-carcinoma sequence.

          Related collections

          Most cited references54

          • Record: found
          • Abstract: found
          • Article: found

          Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors

          Understanding tumor origins and the similarities and differences between organ-specific cancers is important for determining treatment options. Young et al. generated more than 72,000 single-cell transcriptomes from healthy and cancerous human kidneys. From these data, they determined that Wilms tumor, a pediatric kidney cancer, originates from aberrant fetal cells, whereas adult kidney cancers are likely derived from a specific subtype of proximal convoluted tubular cell. Science , this issue p. [Related article:] 594 Single-cell mRNAs of normal and cancerous kidney cells reveal the cellular identity of childhood and adult tumors. Messenger RNA encodes cellular function and phenotype. In the context of human cancer, it defines the identities of malignant cells and the diversity of tumor tissue. We studied 72,501 single-cell transcriptomes of human renal tumors and normal tissue from fetal, pediatric, and adult kidneys. We matched childhood Wilms tumor with specific fetal cell types, thus providing evidence for the hypothesis that Wilms tumor cells are aberrant fetal cells. In adult renal cell carcinoma, we identified a canonical cancer transcriptome that matched a little-known subtype of proximal convoluted tubular cell. Analyses of the tumor composition defined cancer-associated normal cells and delineated a complex vascular endothelial growth factor (VEGF) signaling circuit. Our findings reveal the precise cellular identities and compositions of human kidney tumors.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The broken cycle: E2F dysfunction in cancer

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Hypoxia requires notch signaling to maintain the undifferentiated cell state.

              In addition to controlling a switch to glycolytic metabolism and induction of erythropoiesis and angiogenesis, hypoxia promotes the undifferentiated cell state in various stem and precursor cell populations. Here, we show that the latter process requires Notch signaling. Hypoxia blocks neuronal and myogenic differentiation in a Notch-dependent manner. Hypoxia activates Notch-responsive promoters and increases expression of Notch direct downstream genes. The Notch intracellular domain interacts with HIF-1alpha, a global regulator of oxygen homeostasis, and HIF-1alpha is recruited to Notch-responsive promoters upon Notch activation under hypoxic conditions. Taken together, these data provide molecular insights into how reduced oxygen levels control the cellular differentiation status and demonstrate a role for Notch in this process.
                Bookmark

                Author and article information

                Journal
                Science Translational Medicine
                Sci. Transl. Med.
                American Association for the Advancement of Science (AAAS)
                1946-6234
                1946-6242
                March 25 2020
                March 25 2020
                March 25 2020
                March 25 2020
                : 12
                : 536
                : eaaw6003
                Affiliations
                [1 ]Excellence Centre for Research, Transfer and High Education for the development of DE NOVO Therapies (DENOTHE), University of Florence, Florence 50139, Italy.
                [2 ]Department of Experimental and Clinical Biomedical Sciences “Mario Serio,” University of Florence, Florence 50139, Italy.
                [3 ]Nephrology, Dialysis and Transplantation Unit, Careggi University Hospital, Florence 50139, Italy.
                [4 ]Nephrology and Dialysis Unit, Meyer Children’s University Hospital, Florence 50139, Italy.
                [5 ]Department of Experimental and Clinical Medicine, Section of Internal Medicine, University of Florence, Florence 50139, Italy.
                [6 ]Department of Urology, Careggi Hospital, University of Florence, Florence 50139, Italy.
                [7 ]Department of Urology, Spedali Civili Hospital, University of Brescia, Brescia 25123, Italy.
                [8 ]Department of Urology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin 10043, Italy.
                [9 ]Department of Urology, S. Orsola-Malpighi Hospital, University of Bologna, Bologna 40138, Italy.
                [10 ]Department of Urology, University of Padua, Padua 35122, Italy.
                [11 ]Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
                [12 ]Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus 8200, Denmark.
                [13 ]Unit of Internal Medicine and Endocrinology, ICS Maugeri I.R.C.C.S., Scientific Institute of Pavia, Pavia 28100, Italy.
                [14 ]Arkana Laboratories, Little Rock, AR 72211, USA.
                [15 ]Division of Nephrology, Medizinische Klinik and Poliklinik IV, Klinikum der LMU München, Munich 80336, Germany.
                [16 ]Histopathology and Molecular Diagnostics, University Hospital Careggi, Florence 50139, Italy.
                Article
                10.1126/scitranslmed.aaw6003
                32213630
                23b7c35c-5c1b-4a16-80dd-c231a6759dd1
                © 2020

                http://www.sciencemag.org/about/science-licenses-journal-article-reuse

                History

                Comments

                Comment on this article